Kotani Yumiko, Yokota Ichiro, Kitamura Seiko, Matsuda Junko, Naito Etsuo, Kuroda Yasuhiro
Department of Pediatrics, School of Medicine, University of Tokushima, 3-kuramoto cho, Japan.
Clin Endocrinol (Oxf). 2004 Oct;61(4):418-23. doi: 10.1111/j.1365-2265.2004.02041.x.
The aim of this study was to examine plasma adiponectin concentrations during perinatal the period and their correlations with fetal anthropometric parameters and other hormones.
Venous cord blood samples were obtained from 59 full-term healthy newborns (36 males and 23 females, gestational age 37.0-41.4 weeks, birth weight 2,146-4,326 g, birth length 44.0-54.5 cm). The blood samples were also obtained from 15 neonates (postnatal day 3-7) whose cord blood had already been collected and the changes in adiponectin concentrations were examined.
The adiponectin concentration was determined by enzyme-linked immunosorbent assay. The leptin concentration was determined by radioimmunoassay. Insulin, GH and IGF-1 concentrations were determined by immunoradiometric assays.
The plasma adiponectin concentrations in cord blood ranged from 6.0 to 55.8 microg/ml (median 22.4 microg/ml), which were much higher than those in normal-weight adults (P < 0.0001). In contrast to the findings in adults, these values were positively correlated with birth weight (r = 0.43, P = 0.0005), body mass index (r = 0.44, P = 0.0005), birth weight/birth length ratio (r = 0.46, P = 0.0002) and the leptin concentrations (r = 0.39, P = 0.004). When the effects of fat mass-related anthropometric parameters such as the birth weight/birth length ratio were controlled, plasma adiponectin concentrations had a significant inverse correlation with insulin concentrations (r = -0.35, P = 0.01). There was no significant gender difference in adiponectin concentrations among newborns. The adiponectin concentrations in neonates (postnatal day 3-7) did not change significantly compared with those in cord blood.
In contrast to the findings in adults, these results suggest that the adiponectin concentration increases with the mass of fetal fat.
本研究旨在检测围产期血浆脂联素浓度及其与胎儿人体测量参数和其他激素的相关性。
从59名足月健康新生儿(36名男性和23名女性,胎龄37.0 - 41.4周,出生体重2146 - 4326克,出生身长44.0 - 54.5厘米)采集脐静脉血样本。还从15名已采集脐血的新生儿(出生后第3 - 7天)采集血样本,检测脂联素浓度的变化。
采用酶联免疫吸附测定法测定脂联素浓度。采用放射免疫测定法测定瘦素浓度。采用免疫放射测定法测定胰岛素、生长激素和胰岛素样生长因子-1浓度。
脐血中血浆脂联素浓度范围为6.0至55.8微克/毫升(中位数22.4微克/毫升),远高于正常体重成年人(P < 0.0001)。与成年人的研究结果相反,这些值与出生体重(r = 0.43,P = 0.0005)、体重指数(r = 0.44,P = 0.0005)、出生体重/出生身长比值(r = 0.46,P = 0.0002)和瘦素浓度(r = 0.39,P = 0.004)呈正相关。当控制出生体重/出生身长比值等与脂肪量相关的人体测量参数的影响时,血浆脂联素浓度与胰岛素浓度呈显著负相关(r = -0.35,P = 0.01)。新生儿脂联素浓度无显著性别差异。与脐血相比,新生儿(出生后第3 - 7天)的脂联素浓度无显著变化。
与成年人的研究结果相反,这些结果表明脂联素浓度随胎儿脂肪量增加而升高。